EMR vs PH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 05, 2026
EMR
59.8
AI Score
VS
PH Wins
PH
64.7
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | EMR | PH | Winner |
|---|---|---|---|
| Revenue | 15.74B | 13.78B | PH |
| Net Income | 2.56B | 1.94B | PH |
| Net Margin | 16.2% | 14.1% | PH |
| ROE | 17.5% | 9.5% | PH |
| ROA | 8.3% | 4.6% | PH |
| Total Assets | 30.68B | 42.21B | EMR |
| Current Ratio | 1.13 | 0.90 | PH |
| Free Cash Flow | 2.34B | 2.62B | EMR |
Relative Price Performance (Last 90 Days)
EMR 1M: -2.6%
· 3M: +10.6%
PH 1M: -10.0%
· 3M: +9.1%
Current Technical Phase
EMR
NeutralHold
Mixed signals - no dominant trend phase, RSI 49
PH
NeutralHold
Mixed signals - no dominant trend phase, RSI 41
Fundamentals Snapshot
| Metric | EMR | PH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 21.1 | 28.1 |
| Trailing P/E | 32.9 | 33.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.5% | 0.4% |
| Operating Margin | 0.3% | 0.2% |
| EPS | 4.57 | 28.94 |
| Dividend Yield | 0.01% | 0.01% |
Frequently Asked Questions
Based on our detailed analysis, PH is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.